A scientific meeting analyses the treatment of cardiovascular diseases such as atherosclerosis

The University of Valencia and the Endothelial Cell Research Group of the INCLIVA Health Research Institute are organising an event starting Wednesday and ending today, Friday, at the Faculty of Medicine and Dentistry of the UV, to promote collaboration to address cardiovascular diseases such as atherosclerosis, a chronic condition that affects blood vessels, mainly arteries, due to the accumulation of fats, cholesterol and other substances.

The event, which will be held under the direction of the Professor of Physiology of the University of Valencia Susana Novella, has the purpose of strengthening the European network based on omics technologies and data integration through machine learning and artificial intelligence. 85 experts from the work teams of the European COST Action AtheroNET-Red meet.

The meeting, inaugurated by Carlos Hermenegildo, vice-rector for Research at the UV, mainly aims to guarantee efficient management and promote collaboration and the exchange of knowledge between participants. This is carried out through activities that involve the coordination of work groups, monitoring of project objectives and the establishment of future strategies and plans.

AtheroNET aims to facilitate collaboration between researchers and experts in the field of atherosclerotic cardiovascular disease, to implement omics approaches and data integration through machine learning and artificial intelligence.

"The relevance and novelty of this action lies in the need to address cardiovascular diseases with new technologies, which represent one of the main causes of morbidity and mortality worldwide. Using omics approaches can help design more precise prevention strategies and personalised treatment, which improves clinical outcomes in patients", explains Dr. Susana Novella.